Cube RM, a Scale Up Cohort 4 member, helps Life Sciences companies boost their revenue and productivity by simplifying the complex process of managing tenders (bids for contracts). Using AI and advanced technologies, Cube RM finds more tender opportunities and helps companies make better decisions on pricing and proposals. This takes the guesswork out of the bidding process and makes it more strategic.

A pharmaceutical company looking to bid on a contract to supply medical equipment can use Cube RM to identify the best opportunities and get tailored pricing recommendations based on market trends. This approach he

Cube RM is trusted by Boston Scientific, Pfizer, Bavarian Nordic, and others. In 2021, Cube RM raised an $8M round led by Marathon Venture Capital.

Cube RM in Three:

What problem is Cube RM solving? Cube RM addresses the challenges of tender management in Life Sciences by providing an AI-driven platform to streamline proposal evaluation and pricing strategies.

What’s innovative about Cube RM? Cube RM uses state-of-the-art technologies like Natural Language Processing and Machine Learning to identify tender opportunities and optimize pricing, making the tender process more strategic and effective.

Who can use Cube RM’s services? Life Sciences organizations of any size looking to enhance their tendering process, boost revenue growth, and make data-driven pricing decisions.